Insmed
NASDAQ: INSMIncorporated in Virginia · 1,767 employees on LinkedIn · 6 known investors
Find your way into Insmed
158 people in our graph share verified history with the Insmed team — schools, employers, funds. One of them is your warm intro.
Will Bruneunlockedknows Will Lewis · together at Case Western Reserve University
×9knows the team · via Case Western Reserve University
×2knows the team · via Oberlin College
Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.
Founders & leadership
WL
Will LewisinChair and Chief Executive OfficerWill Lewis has held roles in government, investment banking, and biopharmaceuticals, and has served as Chair and Chief Executive Officer of Insmed since 2012, leading its growth into a company of over 1,700 employees focused on serious lung diseases.
GA
Geoffrey AllaninCEOformer
SB
Sara BonsteininChief Financial Officer
RA
Roger AdsettChief Operating Officer
MF
Martina FlammerinChief Medical OfficerMartina Flammer is a physician-executive with over 20 years in biopharmaceutical leadership, holding an MD from the University of Vienna Medical School and an MBA from NYU Stern. She previously held roles including Chief Medical Officer at Boehringer Ingelheim and VP of Clinical Development and Medical Affairs there, as well as leadership positions at Pfizer, and now serves as Chief Medical Officer at Insmed.
SN
S. Nicole SchaefferinChief People Strategy OfficerS. Nicole Schaeffer is Chief People Strategy Officer at Insmed, with over 25 years of experience in human resources, organizational development, and corporate operations across life science companies.
MA
Michael A. SmithChief Legal Officer
Investors · 6
Acquisitions · 2
Early investors' stakes continue via these dealsAdrestia Therapeutics
Early-stage drug discovery platform, acquired by Insmed
Transave
Transave was a biopharmaceutical company developing inhaled liposomal antibiotic therapies for serious lung infections, including its lead candidate Arikace for cystic fibrosis-related pseudomonas infections.
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Insmed do?
- Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.
- Who are Insmed's investors?
- Insmed's investors include Bessemer Venture Partners, F-Prime Capital, Foresite Capital, OrbiMed, Prospect Venture Partners, NVIDIA.